Literature DB >> 9598682

Factors associated with psychotic symptoms in Alzheimer's disease.

N Hirono1, E Mori, M Yasuda, Y Ikejiri, T Imamura, T Shimomura, M Ikeda, M Hashimoto, H Yamashita.   

Abstract

OBJECTIVES: Many clinical and biological factors have been reported to be associated with the presence of psychosis in patients with Alzheimer's disease, although the associations were variable. The aim of this study was to clarify factors associated with the presence of psychosis in patients with Alzheimer's disease.
METHODS: Psychiatric functioning was studied in 228 patients with Alzheimer's disease based on the results of the behavioural pathology in Alzheimer's disease rating scale or the neuropsychiatric inventory. The effects of sex, education level, age, duration of illness, cognitive function, and apolipoprotein E genotype were investigated for dichotomous psychotic status with a multiple logistic regression analysis.
RESULTS: Of the 228 patients with Alzheimer's disease, 118 (51.8%) showed evidence of delusions or hallucinations. Of these, 94 had delusions only, three had hallucinations only, and 21 had both. Older age, female sex, longer duration of illness, and more severe cognitive impairment were the factors independently associated with the presence of psychosis. The presence of psychosis was not significantly related to either educational level or apolipoprotein E genotype.
CONCLUSIONS: Age, sex, and severity of illness were independent factors associated with the presence of psychosis in patients with Alzheimer's disease. The reason why some patients with Alzheimer's disease develop psychosis remains unclear. There may be distinctive subtypes of Alzheimer's disease or the presence of individual factors which affect the development of psychosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598682      PMCID: PMC2170086          DOI: 10.1136/jnnp.64.5.648

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

Review 1.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Authors:  I G McKeith; D Galasko; K Kosaka; E K Perry; D W Dickson; L A Hansen; D P Salmon; J Lowe; S S Mirra; E J Byrne; G Lennox; N P Quinn; J A Edwardson; P G Ince; C Bergeron; A Burns; B L Miller; S Lovestone; D Collerton; E N Jansen; C Ballard; R A de Vos; G K Wilcock; K A Jellinger; R H Perry
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

2.  The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.

Authors:  O L Lopez; M I Kamboh; J T Becker; D I Kaufer; S T DeKosky
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

3.  SPECT findings on psychosis in Alzheimer's disease.

Authors:  K J Kotrla; R C Chacko; R G Harper; S Jhingran; R Doody
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

4.  A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease.

Authors:  M Sano; D P Devanand; M Richards; L W Miller; K Marder; K Bell; G Dooneief; F W Bylsma; G Lafleche; M Albert
Journal:  Arch Neurol       Date:  1995-10

5.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

6.  Psychopathology and cognitive decline in dementia.

Authors:  D Becker; M Hershkowitz; N Maidler; M Rabinowitz; S Floru
Journal:  J Nerv Ment Dis       Date:  1994-12       Impact factor: 2.254

7.  Clinical variables associated with psychosis in Alzheimer's disease.

Authors:  K J Kotrla; R C Chacko; R G Harper; R Doody
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

8.  Delusions and dementia: clinical and CT correlates.

Authors:  G Binetti; A Padovani; E Magni; A Bianchetti; A Scuratti; G L Lenzi; M Trabucchi
Journal:  Acta Neurol Scand       Date:  1995-04       Impact factor: 3.209

9.  Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.

Authors:  M Lehtovirta; H Soininen; S Helisalmi; A Mannermaa; E L Helkala; P Hartikainen; T Hänninen; M Ryynänen; P J Riekkinen
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

10.  Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease.

Authors:  R Migliorelli; G Petracca; A Tesón; L Sabe; R Leiguarda; S E Starkstein
Journal:  Psychol Med       Date:  1995-05       Impact factor: 7.723

View more
  18 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Neurobiology of delusions, memory, and insight in Alzheimer disease.

Authors:  David L Sultzer; Lorraine P Leskin; Rebecca J Melrose; Dylan G Harwood; Theresa A Narvaez; Timothy K Ando; Mark A Mandelkern
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-08       Impact factor: 4.105

3.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

4.  Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.

Authors:  Robyn Carson; David Craig; Dominic Hart; Stephen Todd; Bernadette McGuinness; Janet A Johnston; Francis A O'Neill; Craig W Ritchie; A Peter Passmore
Journal:  Neuromolecular Med       Date:  2008-08-12       Impact factor: 3.843

5.  Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.

Authors:  Julia Kim; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

6.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

7.  The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.

Authors:  A L Pritchard; J Harris; C W Pritchard; J Coates; S Haque; R Holder; P Bentham; C L Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

8.  Cerebral correlates of psychotic symptoms in Alzheimer's disease.

Authors:  M S Mega; L Lee; I D Dinov; F Mishkin; A W Toga; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 9.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.

Authors:  Jeremy Koppel; Chris Acker; Peter Davies; Oscar L Lopez; Heidy Jimenez; Miriam Azose; Blaine S Greenwald; Patrick S Murray; Caitlin M Kirkwood; Julia Kofler; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2014-03-06       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.